UK markets open in 4 hours 36 minutes
NIKKEI 225
32,256.19 -314.84 (-0.97%) HANG SENG
17,694.14 +38.73 (+0.22%) CRUDE OIL
90.10 +0.47 (+0.52%) GOLD FUTURES
1,944.40 +4.80 (+0.25%) DOW
34,070.42 -370.46 (-1.08%) Bitcoin GBP
21,665.45 -317.54 (-1.44%)
Abbott Laboratories (0Q15.IL)
IOB - IOB Delayed price. Currency in USD
Add to watchlist
At close: 06:48PM BST
| Previous close | 100.82 |
| Open | 0.00 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 82,013 |
| Market cap | 176.468B |
| Beta (5Y monthly) | 0.67 |
| PE ratio (TTM) | 34.02 |
| EPS (TTM) | 2.93 |
| Earnings date | 17 Oct 2023 - 23 Oct 2023 |
| Forward dividend & yield | 2.04 (2.02%) |
| Ex-dividend date | 13 Jul 2023 |
| 1y target est | N/A |
ZacksAbbott (ABT) Stock Moves -1.35%: What You Should Know
Abbott (ABT) closed at $98.93 in the latest trading session, marking a -1.35% move from the prior day.
ZacksAbbott (ABT) to Commercialize Biosimilars in Emerging Markets
Abbott (ABT) is set to commercialize several biosimilar molecules in key emerging markets via an expanded collaboration with mAbxience.
ZacksAll You Need to Know About Abbott (ABT) Rating Upgrade to Buy
Abbott (ABT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
© 2023 Yahoo. All rights reserved.
